These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 7888206)

  • 21. Regulated expression of a dominant negative form of Rev improves resistance to HIV replication in T cells.
    Liu J; Woffendin C; Yang ZY; Nabel GJ
    Gene Ther; 1994 Jan; 1(1):32-7. PubMed ID: 7584057
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Defective lentiviral vectors are efficiently trafficked by HIV-1 and inhibit its replication.
    Klimatcheva E; Planelles V; Day SL; Fulreader F; Renda MJ; Rosenblatt J
    Mol Ther; 2001 Jun; 3(6):928-39. PubMed ID: 11407907
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antitat gene therapy: a candidate for late-stage AIDS patients.
    Lisziewicz J; Sun D; Lisziewicz A; Gallo RC
    Gene Ther; 1995 May; 2(3):218-22. PubMed ID: 7614253
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recombinant human immunodeficiency virus type 1 genomes with tat unconstrained by overlapping reading frames reveal residues in Tat important for replication in tissue culture.
    Neuveut C; Jeang KT
    J Virol; 1996 Aug; 70(8):5572-81. PubMed ID: 8764071
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of antitat gene therapy in the presence of high multiplicity infection and inflammatory cytokines.
    Lisziewicz J; Sun D; Gallo RC; Ensoli B; Lori F
    Hum Gene Ther; 1996 Dec; 7(18):2209-16. PubMed ID: 8953311
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of human immunodeficiency virus type 1 by Tat/Rev-regulated expression of cytosine deaminase, interferon alpha2, or diphtheria toxin compared with inhibition by transdominant Rev.
    Ragheb JA; Couture L; Mullen C; Ridgway A; Morgan RA
    Hum Gene Ther; 1999 Jan; 10(1):103-12. PubMed ID: 10022535
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic modification of human peripheral blood lymphocytes with a transdominant negative form of Rev: safety and toxicity.
    Fox BA; Woffendin C; Yang ZY; San H; Ranga U; Gordon D; Osterholzer J; Nabel GJ
    Hum Gene Ther; 1995 Aug; 6(8):997-1004. PubMed ID: 7578421
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High level inhibition of HIV replication with combination RNA decoys expressed from an HIV-Tat inducible vector.
    Fraisier C; Irvine A; Wrighton C; Craig R; Dzierzak E
    Gene Ther; 1998 Dec; 5(12):1665-76. PubMed ID: 10023446
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of Tat-encoding bicistronic human immunodeficiency virus type 1 gene transfer vectors in primary canine bone marrow mononuclear cells.
    Srinivasakumar N; Zaboikin M; Zaboikina T; Schuening F
    J Virol; 2002 Jul; 76(14):7334-42. PubMed ID: 12072532
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of human immunodeficiency virus type 1 (HIV-1) replication by HIV-1-based lentivirus vectors expressing transdominant Rev.
    Mautino MR; Keiser N; Morgan RA
    J Virol; 2001 Apr; 75(8):3590-9. PubMed ID: 11264348
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A lentiviral vector that activates latent human immunodeficiency virus-1 proviruses by the overexpression of tat and that kills the infected cells.
    Macías D; Oya R; Saniger L; Martín F; Luque F
    Hum Gene Ther; 2009 Nov; 20(11):1259-68. PubMed ID: 19604078
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TAR- and Tat-independent replication of human immunodeficiency virus type 1 in human hepatoma cells.
    Zhu M; Duan L; Pomerantz RJ
    AIDS Res Hum Retroviruses; 1996 Aug; 12(12):1093-101. PubMed ID: 8844014
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prolonged systemic expression of human IL-1 receptor antagonist (hIL-1ra) in mice reconstituted with hematopoietic cells transduced with a retrovirus carrying the hIL-1ra cDNA.
    Boggs SS; Patrene KD; Mueller GM; Evans CH; Doughty LA; Robbins PD
    Gene Ther; 1995 Nov; 2(9):632-8. PubMed ID: 8548552
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Block of HIV-1 infection by a combination of antisense tat RNA and TAR decoys: a strategy for control of HIV-1.
    Chang HK; Gendelman R; Lisziewicz J; Gallo RC; Ensoli B
    Gene Ther; 1994 May; 1(3):208-16. PubMed ID: 7584083
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Retroviral gene transfer and sustained expression of human arylsulfatase A.
    Learish R; Ohashi T; Robbins PA; Bahnson A; Boggs SS; Patrene K; Schwartz BE; Gieselmann V; Barranger JA
    Gene Ther; 1996 Apr; 3(4):343-9. PubMed ID: 8732166
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A third-generation lentivirus vector with a conditional packaging system.
    Dull T; Zufferey R; Kelly M; Mandel RJ; Nguyen M; Trono D; Naldini L
    J Virol; 1998 Nov; 72(11):8463-71. PubMed ID: 9765382
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Helper virus-free transfer of human immunodeficiency virus type 1 vectors.
    Richardson JH; Kaye JF; Child LA; Lever AM
    J Gen Virol; 1995 Mar; 76 ( Pt 3)():691-6. PubMed ID: 7897357
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rhesus monkey model for fetal gene transfer: studies with retroviral- based vector systems.
    Tarantal AF; O'Rourke JP; Case SS; Newbound GC; Li J; Lee CI; Baskin CR; Kohn DB; Bunnell BA
    Mol Ther; 2001 Feb; 3(2):128-38. PubMed ID: 11237669
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Requirement of the human immunodeficiency virus type 1 env gene sequence for TAR-independent trans activation by Tat from the major immediate-early promoter of murine cytomegalovirus.
    Kim YS
    Biochem Biophys Res Commun; 1994 Sep; 203(2):1152-9. PubMed ID: 8093034
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Myeloproliferative sarcoma virus directed expression of beta-galactosidase following retroviral transduction of murine hematopoietic cells.
    Clapp DW; Freie B; Srour E; Yoder MC; Fortney K; Gerson SL
    Exp Hematol; 1995 Jul; 23(7):630-8. PubMed ID: 7601255
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.